WUXI BIOLOGICS CAYMAN INC USD00000083 144A REG S WXIBF
COM · Common Stock · CUSIP G97008117
1
institutional holders
+0 vs Q1 2021
9.1m
shares reported held*
$167.5mreported value*
0 new
0 added
1 reduced
0 sold out
net sold ≈ $1.8m (-97.5k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $18.32.
Trends to Q2 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2020 | 1 |
| Q1 2021 | 1 |
| Q2 2021 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2021 | 1 | 0 |
| Q2 2021 | 0 | 1 |
Biggest buyers
| None |
Biggest sellers
| GILDER GAGNON HOWE & CO LLC | Reduced | -97.5k |
Holders, Q2 2021
| Manager | Shares | Change |
|---|---|---|
| GILDER GAGNON HOWE & CO LLC 0.82% of their portfolio | 9.1m $167.5m | Reduced -97.5k |